Skip to main content
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Lab Equipment

    Biotech Deal Advances GBA Therapy for Parkinson’s

    Lysosomal Therapeutics announced sale of its therapies against dysfunction linked to mutations in the GBA gene, a common genetic cause of Parkinson’s disease.

  • Default content image

    Ask the PhD: Pursuing a Game-changing Brain Scan for Parkinson's 

    In our latest Ask the PhD video, we talk to staff scientist Jamie Eberling, PhD, about alpha-synuclein imaging and why we are devoting substantial resources to this area of Parkinson’s research.

  • ‘A Cup of Coffee a Day Keeps Dyskinesia Away?’

    Higher Caffeine Linked to Lower Parkinson’s in LRRK2 Mutation Carriers

    Recent research links higher caffeine in the blood samples and diets of people with a LRRK2 genetic mutation, which increases PD risk, with lower Parkinson’s.

  • Genetic testing

    MJFF and Northwestern Partner on Clinical Genetic Testing Series

    The Michael J. Fox Foundation and Northwestern University are co-sponsoring a new two-part educational course, Clinical Genetic Testing for Parkinson’s Disease: Why, When and How? A Virtual CME…

  • Lab Tubes

    Roche Buys MJFF-Grantee Inflazome in Deal to Develop Drugs against Inflammation

    Funding from The Michael J. Fox Foundation advanced biotech Inflazome’s therapeutic portfolio; the deal with Roche brings resources to move further in clinical testing.

  • Positive Results from Parkinson's LRRK2 Drug Trial

    New Therapy for Parkinson’s “Off” Time Reaches FDA

    A continuous apomorphine infusion, which aims to treat significant “off” time not controlled with oral PD meds, is now with the FDA for review.

Gloved hand holding research samples.

Be Part of the Answer

You have the power to impact your future and the future of millions living with Parkinson's disease. Explore clinical research participation today.

Join a Study
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.